Covid-19 pattern in cancer patients-an experience from a tertiary care center of western UP

Surabhi Gupta; Tejashwita Singh

doi:10.30574/gscarr.2021.6.2.0031

Authors

Surabhi Gupta Department of Radiation oncology, S. N. Medical College, Agra (UP), India.
Tejashwita Singh Department of Radiation oncology, S. N. Medical College, Agra (UP), India.

DOI:

https://doi.org/10.30574/gscarr.2021.6.2.0031

Keywords:

cancer, covid-19, infectivity rate, case fatality rate

Abstract

Many researches are published and still going on for the effects of comorbidities on coronavirus disease 2019 (COVID-19), but large studies on cancer as a risk factor and severity of covid-19 in cancer patients are still lacking. The aim of this study was to see the prevalence of covid- 19 in cancer patients and to observe the pattern of disease course in cancer patients undergoing active treatment. In this study, 50 patients of covid-19 RTPCR confirmed cancer patients were enrolled who visited the department from 1may to September 2020 and were retrospectively analyzed for their disease course. Infectivity rate of 5% was observed while case fatality rate was 12%. Mean age of presentation was 42.9yr with male predominance. Head and neck carcinoma patients were more prone to covid-19.20% patients were symptomatic, who required admission in covid ward. Infectivity rate as well as case fatality rate was higher in cancer patients, especially those taking active cancer treatment and were having other comorbid conditions also. Cancer treatment makes a risk factor for covid-19 infection. Mortality is more in cases having associated comorbidities. Though more prospective randomized trials are needed for any statistical analysis.

Metrics

Metrics Loading ...

References

Reynolds Matt. What is coronavirus and how close is it to becoming a pandemic? Wired UK. ISSN 1357-0978. Archived from the original on 5 March 2020.

Reid David. India confirms its first coronavirus case. CNBC. 30 January 2020.

One of the highest globally, India's Recovery Rate now nearly 97%". Press Information Bureau. 28 January 2021.

CoVID news by MIB. 2020.

A 123-yr-old Act to combat coronavirus in India; experts say nothing wrong". Livemint. IANS. 14 March 2020.

Singh AK, Gupta R, Ghosh A, Misra A.” Diabetes in COVID-19: prevalence, pathophysiology, prognosis, and practical considerations”. Diabetes Metab Syndr Clin Res Rev. 2020; 14(4): 303–10.

W Liang, W Guan, R Chen, et al.” Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China”. Lancet Oncol. 2020; 21(3): 335-337.

Z Wu, JM Mc Googan” Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China:” summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention.JAMA 2020.

Wu MY, Li CJ, Yiang GT, Cheng YL, Tsai AP, Hou YT. Et al. “Molecular Regulation of Bone Metastasis Pathogenesis”. Cell Physiol Biochem. 2018; 46: 1423–38.

Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z. et al. “Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak”. Cancer Discov. 2020; 10: 783–91.

Saluja M, Pillai D, Jeliya S, Bauddh N, Chandel R. “COVID 19- Clinical Profile, Radiological Presentation, Prognostic Predictors, Complications and Outcome: A Perspective from the Indian Subcontinent”. J Assoc Physicians India. 2020 Jul; 68(7): 13-18.

Onder G, Rezza G, Brusaferro S.” Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy”. JAMA. 2020; 323: 1775-6.

Trapani D, Marra A, Curigliano G. “The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region”. Eur J Cancer. 2020; 132: 199-206.

Grasselli G, Pesenti A, Cecconi M.” Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast during an Emergency Response. “JAMA. 2020; 323(16): 1545–1546.

Khan M, Khan H, Khan S, Nawaz M. “Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-center study”. J Med Microbial. 2020 Aug; 69(8): 1114-1123.

He et al. (2020) He W, Chen L, Yuan G, Fang Y, Chen W, Wu D, Liang B, Lu X, Ma Y, Li L, Wang H, Chen Z, Li Q, Gale RP.” COVID-19 in persons with hematological cancers”. Leukemia. 2020; 34(6):1637–1645.

Kalinsky et al. (2020) Kalinsky K, Accordino MK, Hosi K, Hawley JE, Trivedi MS, Crew KD, Hershman DL. “Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City”. Breast Cancer Research and Treatment. 2020; 182(1):239–242.